What quality criteria are important for surgical excision of rectal cancer?;Quels sont les critères de qualité de l'exérèse chirurgicale des cancers du rectum?

Gastroenterologie Clinique et Biologique

Volumn 31, Issue HS1, 2007, Pages

  Rullier, Anne ^a   Laurent, Christophe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; GASTROINTESTINAL SURGERY; HEALTH CARE QUALITY; HUMAN; NOTE; RECTUM CARCINOMA;

EID: 34347360541     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (175)

1. Heald RJ, Husband EM, Ryall DH. The mesorectum in rectal cancer surgery. The clue to pelvic recurrence? Br J Surg 1982;69:613-6.
2. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;1,38:996-9.
3. Hermanek P, Hermanek PJ. Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 2000;19:329-35.
4. Bisset IP, Chau KY, Hill GL. Extrafascial excision of the rectum: surgical anatomy of the fascia propria. Dis Colon Rectum 2000;43:903-10.
5. Chapuis P, Bokey L, Fahrer M, Sinclair G, Bogduk N. Mobilization of the rectum: anatomic conceps and the bookshelf revisited. Dis Colon Rectum 2002;45:1-9.
6. Giuly J, Nguyen-Cat R, Francois GF. Extrafascial excision of the mesorectum or total mesorectal excision? Ann Chir 2004;129:68-72.
7. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997;184:584-8.
8. De Calan L, Bourlier P. Le choix des thérapeutiques du cancer du rectum. J Chir 1998;135:51-6.
9. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82.
10. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-46.
11. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
12. Martling LA, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Lancet 2000;356:93-6.
13. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-34.
14. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-9.
15. Machado M, Goldman S, Jarhult J. Improved results in rectal cancer surgery- an effect of specialization? Colorectal Dis 2000;2:264-9.
16. Nesbaken A, NyGaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. EJSO 2002;28:126-34.
17. Kapiteijn E, Putter H, van de Velde JH. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002;89:1142-9.
18. Bulow S, Christensen IJ, Harling H, Kronborg O, Fenger C. Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003;90:974-80.
19. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3:127-31.
20. Nagtegaal ID, van Krieken JHJM. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer an overview. Eur J Cancer 2002;38:964-972.
21. Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004;47:1145-50.
22. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-34.
23. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998;41:55-61.
24. Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002;45:733-42.
25. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996;83:1112-5.
26. Scott N, Jackson P, Al-Jaberi T, Dixon MF, Quirke P, Finan PJ. Total mesorectum excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995;82:1031-3.
27. Hida J, Yasutomi M, Fujimoto K, Maruyama T, Okuno K, Shindo K. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 1997;184:475-80.
28. Ono C, Yoshinaga K, Enomoto M, Sugihara K. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum 2002;45:744-9.
29. Wang Z, Zhou Z, Wang C, Zhao G, Chen Y, Gao H, Zheng X, Wang R, Chen D. Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis 2005;20:231-7.
30. Zhao GP, Zhou ZG, Lei WZ, Yu YY, Wang C, Wang Z, Zheng XL, Wang R. Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 2005;11:319-22.
31. Goligher JC, Dukes CE, Bussey HJR. Local recurrences after sphincter-saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg 1951;39:199-211.
32. Grinnell RS. Distal intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol and Obst 1954;99:421-30.
33. Williams NS, Dixon MF, Johnston D. Reappraisable of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg 1983;70:150-54.
34. Pollett WG, Nicholls RJ. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 1983;198:159-63.
35. Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 1995;76:388-92.
36. Nakagoe T, Yamaguchi 1, Tanaka K, et al. Distal intramural spread is an independent prognostic factor for distant metastasis and poor outcome in patients with rectal cancer: a multivariate analysis. Ann Surg Oncol 2003;10:163-70.
37. Bokey EL, Ojerskog B, Chapuis PH, Dent OF, Newland RC, Sinclair G. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg 1999;86:1164-70.
38. Leo E, Belli F, Andreola S, et al. Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of Milano. Ann Surg Oncol 2000;7:125-32.
39. Ueno H, Mochizuki H, Hashiguchi Y, et al. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 2004;239:34-42.
40. Kuvshinoff B, Maghfoor I, Miedema B, et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are ≤ 1 cm distal margins sufficient? Ann Surg Oncol 2001;8:163-9.
41. Goldstein NS, Soman A, Sacksner J. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol 1999;111:349-51.
42. Speake WJ, Abercrombie JF. Should 'doughnut' histology be routinely performed following anterior resection for rectal cancer? Ann R Coll Surg Engl 2003;85:26-7.
43. Pullyblank AM, Kirwan C, Rigby HS, Dixon AR. Is routine histological reporting of doughnuts justified after anterior resection for colorectal cancer? Colorectal Dis 2001;3:198-200.
44. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004;54:295-308.
45. Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M. Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 1998;85:355-8.
46. Matthiesen P, Hallböök O, Andersson M, Rutegard J, Sjödahl R. Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 2004;6:462-9.
47. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 1998;124:612-8.
48. Leong AF. Selective total mesorectal excison for rectal cancer. Dis Colon Rectum 2000;43:1237-40.
49. Bonadeo FA, Vaccaro CA, Benati ML, Ojea Quintana GM, Garione XE, Telenta MT. Rectal cancer. Local recurrence after surgery without radiotherapy. Dis Colon Rectum 2001;44:374-9.
50. Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002;28:126-34.
51. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 2004;240:260-8.
52. Peeters KC, Tollenaar RA, Marijnen CA, Kranenbarg E, Steup WH, Wiggers T, et al.; for the Dutch Colorectal Cancer Group. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg 2005;92:211-6.
53. Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN; Norvwegian Rectal Cancer Group. Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis 2005;7:51-7.
54. Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F. Sphincter-saving resection for all rectal carcinomas: the end of the 2 cm distal rule. Ann Surg 2005;241:465-9.
55. Lopez MJ, Monafo WW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993;113: 365-72.
56. Luna Perez P, Delgado S, Labastida S. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Ann Surg Oncol 1996;3:526-33.
57. Hida J, Yasutomi M, Maruyama. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastsases. Dis Colon Rectum 1998;41:165-8.
58. Eriksen MT, Wibe A, Syse A, Haffner J, Wiig N. Inadvertent during rectal cancer resection in Norway. Br J Surg 2004;91:210-6.
59. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990;33:610-4.
60. Porter GA, Soskolne CL, Yakimets W, Newman SC. Surgeon related factors and outcome in rectal cancer. Ann Surg 1998;227:157-67.
61. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior versus abdominoperineal resection. Dis Colon Rectum 2004;47:48-58.
62. Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia-Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum 2001;44:1676-81
63. Mannaerts G, Rutten HJ, Martijn H, Groen GJ, Hanssens PE, Wiggers T. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer. Dis Colon Rectum 2001;44:806-14.
64. Ruo L, Paty PB, Minsky BD, Wong WD, Cohen AM, Guillem JG. Results after rectal cancer resection with in-continuity partial vaginectomy and total mesorectal excision. Ann Surg Oncol 2003;10:664-8.
65. Shirouzou K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg 1996;83:32-5.
66. Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000;190:78-83.
67. Liu SY, Wang YN, Zhu WQ. Total pelvic exenteration for locally advanced rectal carcinoma. Dis Colon Rectum 1994;37:172-4.
68. Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002;45:1078-84.
69. Burt CA. Prophylactic oophorectomy with resection of the large bowel for cancer. Am J Surg 1951;82:571-6.
70. MacKeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients. Dis Colon Rectum 1979;22:401-5.
71. Blamey SL, McDermott FT, Pihl E, Price AB, Milne BJ, Hughes ES. Ovarian involvement in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet 1981;153:42-4.
72. Cutait R, Lesser ML, Enker WE. Prophylactic oophorectomy in surgery for large bowel cancer. Dis Colon Rectum 1983;26:6-11.
73. Koves I, Vamoisi-Nagy I, Besznyaak I. Ovarian metastases of colorectal tumors. Eur J Surg Oncol 1993;19:633-5.
74. Ballantyne G, Reigel M, Wolff B, Ilstrup D. Oophorectomy and colon cancer: impact on survival. Ann Surg 1985;202:209-14.
75. Sielezneff I, Salle E, Antoine K, Thirion X, Brunet C, Sastre B. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer. Dis Colon Rectum 1997;40:1299-302.
76. Young-Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM. Prophylactic oophorectomy in colorectal carcinoma. Preliminary results of a randomized, prospective trial. Dis Colon Rectum 1998;41:277-85.
77. McDonald PJ, Heald RJ. A survey of postoperative function after rectal anastomosis with circular stapling devices. Br J Surg 1983;70:727-9.
78. Conférence de consensus. Le choix des thérapeutiques du cancer du rectum. Rev Prat 1995;266:26-34.
79. Maas CP, Moriya Y, Steup WH, Kranenbarg K, van de Velde CJ. A prospective study on radical and nerve-preserving surgery for rectal cancer in Netherlands. Eur J Surg Onc 2000;26:751-7.
80. Maurer CA, Z'Graggen K, Renzulli P, Schilling MK, Netzer P, Buchler MW. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 2001;88:1501-5.
81. Hojo K, Vernava AM, Sugihara K, Katumata K. Preservation of urine avoiding and sexual function after rectal cancer surgery. Dis Colon Rectum 1991;34:532-9.
82. Enker W. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992;127:1396-402.
83. Havenga K, Enker WE, McDermott K, Cohen AM, Minsky BD, Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495-502.
84. Pocard M, Zinzindohue F, Haab F, Caplin S, Parc R, Tiret E. A prospective study of sexual and urinary function before and after mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery 2002;131:368-72.
85. Kim NK, Aahn TW, Park JK, Lee KY, Lee WH, Sohn SK, Min JS. Assessment of sexual and voiding function after total mesorectal excision with pe autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 2002;45:1178-85.
86. Junginger T, Kneist W, Heintz A. Influence of identification and preservation of pelvic autonomic nerves in rectal cancer surgery on bladder dysfunction after total mesorectal excision. Dis Colon Rectum 2003;46:621-8.
87. Moriya Y, Sugihara K, Akasu T, Fujita S. Patterns of recurrence after nerve sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 1995;38:1162-8.
88. Masui H, Ike H, Yamaguchi S, Oki S, Shimada H. Male sexual function after autonomic nerve-preserving operation for rectal cancer. Dis Colon Rectum 1996;39:1140-5.
89. Tiret E, Pocard M. Exérèse totale du mésorectum et conservation de l'innervation à destinée génito-urinaire dans la chirurgie du cancer du rectum. Ann Chir 1999;53:507-14.
90. Lindsey I, Guy RJ, Warren BF, Mortensen NJ. Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 2000;87:1288-99.
91. Heald RJ, Moran BJ, Brown G, Daniels IR. Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers' fascia. Br J Surg 2004;91:121-3.
92. Goligher JC. The blood-supply to the sigmoid colon and rectum with reference to the technique of rectal resection with restoration of continuity. Br J Surg 1949;37:157-62.
93. Pezim ME, Nicholls RJ. Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 1984;200:729-33.
94. Surtees P, Ritchie JK, Phillips RK. High versus low ligation of the inferior mesenteric artery in rectal cancer. Br J Surg 1990;77:618-21.
95. Kim JC, Lee KH, Yu CS, Kim HC, Kim JR, Chang HM, Kim JH, Kim JS, Kim TW. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol 2004;30:271-9.
96. Dworkin MJ, Allen-Mersh TG. Effect of inferior mesenteric artery ligation on blood flow in the marginal artery-dependent sigmoid colon. J Am Coll Surg 1996;183:357-60.
97. Hida J, Yasutomi M, Maruyama T, Uchida T, Nakajima A, Wakano T, Tokoro T, Kubo R. High ligation of the inferior mesenteric artery with hypogastric nerve preservation in rectal cancer surgery. Surg Today. 1999;29:482-3.
98. Villemin F, Haurd P, Montagne M. Recherches anatomiques sur les lymphatiques du rectum et de l'anus. Rev Chir 1925;63:39-80.
99. Blair JB, Holyoke DA, Best RR. A note on the lymphatics of the middle and lower rectum and anus. Anat Rec 1950;108:635-44.
100. Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951;81:111-20.
101. Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982;144:350-4.
102. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection foe advanced rectal carcinoma at or below the peritoneal reflection. Dis colon Rectum 1989;32: 307-315.
103. Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today 1995;25:795-801.
104. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for lower rectal cancer. World J Surg 1997,27:728-32.
105. Fujita S, Yamamoto S, Akasu T, Moriya Y. Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 2003;90:1580-5.
106. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 2000;43:S59-S68.
107. Moreira LF, Hizuta A, Iwagaki H, Tanakz N, Orita K. Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection. Br J Surg 1994;81:293-296.
108. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001;44:1274-80.
109. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1,411 patients. Eur J Oncol 1999;25:368-374.
110. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659-63.
111. Skipper D, Cooper AJ, Martson JE Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049-52.
112. McGregor JR, Galloway DJ, McCulloch P, Georges WD. Anastomotic suture materials and implantation metastasis: an experimental study. Br J Surg 1989;76:331-4.
113. Anderberg B, Enblad P, Sjodahl R, Watterfors J. Recurrent carcinoma after anterior resection and rectal stapling. Br J Surg 1983;70:1-4.
114. Gertsch P, Baer HU, Kraft R, Maddern GJ, Altermatt HJ. Dis Colon Rectum 1992;35: 238-41.
115. Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 1984;66:192-4.
116. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O'Dwyer PJ. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg 1995;82:1050-2.
117. Heald RJ, Moran BJ, Ryall RD, Sexton R, McFarlane JK. Rectal cancer - The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998;133:894-9.
118. Jenner DC, Boer WB, Clarke G, Lewitt MD. Rectal washout eliminates exfoliated malignant cells. Dis Colon Rectum 1998;41:1432-4.
119. Sayfan J, Averbuch F, Koltum L, Benyamin N. Effect of rectal stump washout on the presence of free malignant cells in the rectum during anterior resection for rectal cancer. Dis Colon Rectum 2000;43:1710-2.
120. Tytherleigh MG, McC Mortensen NJ. Options for sphincter preservation in surgery for low rectal cancer. Br J Surg 2003;90:922-33.
121. Maeda K, Maruta M, Hanai T, Sato H, Horibe Y. Irrigation volume determines the efficacy of rectal washout. Dis Colon Rectum 2004;47:1706-10.
122. Agaba EA. Does rectal washout during anterior resection prevent local tumor recurrence? Dis Colon Rectum 2004;47:291-6.
123. Byrne CM, Perera DS, King DW. Does rectal washout during anterior resection prevent local tumor recurrence? Dis Colon Rectum 2005;48:172-3.
124. Foster CB. Adverse relationship between blood transfusion and survival after colectomy for colon cancer. Cancer 1985;55:1195-201.
125. Blumberg N, Heal JM. Perioperative blood transfusion and solid tumor recurrence. Cancer Invest 1987;5:615-25.
126. Amato AC, Pescatori M. Effect of peroperative blood transfusions on recurrence of colorectal cancer. Dis Colon Rectum 1998;41:570-85.
127. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogenic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of uncoufounded studies. Br J Surg 1998;85:171-8.
128. van de Watering LMG, Brand A, Houbiers JGA, Kranenbarg WM, Herman J, van de Velde CJH. Perioperative blood transfusions, with or without allogeneic leucocytes, relate survival, not to cancer recurrence. Br J Surg 2001;88:267-72.
129. Bush OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a non causal relationship. Ann Surg 1994;220:791-7.
130. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P. Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery 2001;129:433-9.
131. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF, Quirke P. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
132. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-57.
133. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-9.
134. Hall NR, Finan PJ, Al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998;41:979-83.
135. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, van de Velde CJH, van Krieken JHJM. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two millimetres is the limit. Am J Surg Pathol 2002;26:350-7.
136. Rullier A, Laurent C, Vendrely V, Le Bail B, Bioulac-Sage P, Rullier E. Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2005;29:602-6.
137. Goldberg PA, Nicholls RJ. Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local clearance. Br J Surg 1995;82:1054-6.
138. Martling A, Singnomklao T, Holm T, Rutqvist LE, Cedermark B. Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Br J Surg 2004;91:1040-5.
139. American Joint Committee on Cancer. Colon and rectum. In: Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven Publishers;1997:83-90.
140. Monges G, Piard F. Recommendations for pathologic reporting of resected colonic neoplasms. Gastroenterol Clin Biol 1998;22:S126-30.
141. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666-72.
142. Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the lerge bowel. A French population-based study. Cancer 1998;82:1482-6.
143. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165-7.
144. Cserni G, Vadja K, Tarjan M, Bori R, Vajda K, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5:291-6.
145. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a conclusion for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209-16.
146. Thorn CC, Woodcock NP, Scott N, Verbeke C, Scott SB, Ambrose NS. What factors affect lymph node yield in surgery for rectal cancer? Colorect Dis 2004;6:356-61.
147. Pocard M, Panis Y, Malassagne B, Nemeth J, Hautefeuille P, Valleur P. Assessing the effectiveness of mesorectal excision in rectal cancer. Prognostic value of the number of lymph nodes found in resected specimens. Dis Colon Rectum 1998;41:839-45.
148. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896-900.
149. Nagtegaal ID, van Krieken JH. The role of pathologists in the quality control of diagnosis and treatment of rectal cance an overview. Eur J Cancer 2002;38:964-72.
150. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 1989;3:96-9.
151. Andreola S, Leo E, Belli F, Bufalino R, Tomasic G, Lavarino C, Baldini MT, Meroni E. Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm. Cancer 1996;77:607-12.
152. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-63.
153. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, et al. and the Pathology Review Committee. Short term preoperative radiotherapy interferes with determination of pathological parameters in rectal cancer. J Pathol 2002;197:20-7.
154. Marijnen CAM, Nagtegaal ID, Kranenbarg EK, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19:1976-84.
155. Wichmann MW, Muller C, Meyer G, Strauss T, Hornung HM, Lauwerner U, Angele MK, Schildberg FW. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 2002;137:206-10.
156. Luna-Perez P, Rodriguez-Ramirez S, Alvarado I, Gitierrez de la Barrera M, Labastida S. Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res 2003;34:281-6.
157. Lieffers GJ, Cleton-Jansen AM, van de Velde CJH, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
158. Andreola S, Leo E, Belli F, Gallino G, Sirizzotti G, Sampietro G. Adenocarcinoma of the lower third of the rectum: metastases in lymph nodes smaller than 5 mm and occult micrometastases; preliminary results on early tumour recurrence. Ann Surg Oncol 2001;8:413-7.
159. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix. Arch Pathol Lab Med 2000;124:1016-25.
160. Piard F, Martin L, Chapusot C, Ponnelle T, Monges G. New histologic prognostic factors in colorectal cancer. Gastroenterol Clin Biol. 2002;26:B62-73.
161. Bilchik A, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128-36.
162. Bembenek A, Rau B, Moesta T, et al. Sentinel lymph node biopsy in rectal cancer-not yet ready for routine clinical use. Surgery 2004;135:498-505.
163. Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997;84:657-63.
164. Blomqvist P, Ekbom A, Nyrén O, Krusemo UB, Bergström R, Adami, HO. Survival after rectal cancer: differences between hospital catchment areas. A nationwide study in Sweden. Gut 1999;45:39-44.
165. Simons AJ, Ker R, Groshen S, Gee C, Anthone GJ, Ortega AE, Vukasin P, Ross RK, Beart RW. Variations in treatment of rectal cancer. Dis Colon Rectum 1997;40:641-646.
166. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg 2001;88:1397-1402.
167. Meyerhardt J, Tepper J, Niedzwiecki D, Hollis D, Schrag D, Ayanian J, O'Connell M, Weeks J, Willett C, MacDonald J, Benson AlB, Fuchs C. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer. Finding from the intergroup 0114 study. J Clin Oncol 2004;22:166-174.
168. Schrag D, Panageas KS, Riedel E, Cramer LD, Guillem JG, Bach PB, Begg CB. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002;236:583-92.
169. Hermanek P and Hohenberger W. The importance of volume in colorectal cancer surgery. Eur J Surg Oncol 1996;22:213-5.
170. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002;89:1008-13.
171. Garcia-Granero E, Marti-Obiol R, Gomez-Barbadillo J, Garcia-Armengol J, Esclapez P, Espi A, Jimenez E, Millan M, Lledo S. Impact of surgeon organisation and specialization in rectal cancer outcome. Colorectal Disease 2001;3:179-184.
172. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg 2004;91:610-7.
173. Smith JAE, King PN, Lane RHS, Thompson MR. Evidence of the effect of specialization on the management surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 2003;90:583-592.
174. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-6.
175. Kapiteijn E, van de Velde CJH. Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002;38:919-36.